Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 6/2008

01-06-2008 | Article

Detection of measles- and mumps-specific IgG antibodies in paired serum and oral fluid samples from Norwegian conscripts

Authors: K. Vainio, H. H. Samdal, G. Ånestad, E. Wedege, D. H. Skutlaberg, K. T. Bransdal, R. Mundal, I. S. Aaberge

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 6/2008

Login to get access

Abstract

The aim of this study was to measure the seroprevalence to mumps in Norwegian conscripts belonging to the first children vaccination cohorts that had been offered two doses of MMR vaccine. The seroprevalence to mumps was 76% with the Microimmune assay and 85% with the Enzygnost assay. We also compared the performance of the Microimmune assay for detection of mumps- and measles-specific IgG antibodies in 340 paired serum and oral fluid samples from the conscripts and evaluated the effect of revaccination. Mumps-specific IgG antibodies were detected in only 61% of the oral fluids. In contrast, high levels of measles-specific IgG antibodies were detected in both the serum and oral fluid samples. Based on these results, we are only able to recommend the use of oral fluid for surveillance of measles in Norway. Our results may also indicate that the seroprevalence necessary to interrupt transmission of mumps has not been reached in vaccinated young adult Norwegians. Seroconversion was observed in all initially measles seronegative conscripts after revaccination, whereas 23 of 27 initially mumps seronegative conscripts failed to seroconvert.
Literature
1.
go back to reference Anonymous (2002) Measles and measles immunization in Norway; historical review and present situation. Eurosurveillance 6 Anonymous (2002) Measles and measles immunization in Norway; historical review and present situation. Eurosurveillance 6
3.
go back to reference Vainio K, Samdal HH, Anestad G, Skutlaberg DH, Bransdal KT, Mundal R, Aaberge I (2007) Seroprevalence of measles among Norwegian military conscripts in 2004. Eur J Clin Microbiol Infect Dis 26:217–220PubMedCrossRef Vainio K, Samdal HH, Anestad G, Skutlaberg DH, Bransdal KT, Mundal R, Aaberge I (2007) Seroprevalence of measles among Norwegian military conscripts in 2004. Eur J Clin Microbiol Infect Dis 26:217–220PubMedCrossRef
4.
go back to reference Parry JV, Perry KR, Mortimer PP (1987) Sensitive assays for viral antibodies in saliva: an alternative to tests on serum. Lancet 2:72–75PubMedCrossRef Parry JV, Perry KR, Mortimer PP (1987) Sensitive assays for viral antibodies in saliva: an alternative to tests on serum. Lancet 2:72–75PubMedCrossRef
5.
go back to reference Backhouse JL, Gidding HF, McIntyre PB, Gilbert GL (2006) Evaluation of two enzyme immunoassays for detection of immunoglobulin G antibodies to mumps virus. Clin Vaccine Immunol 13:764–767PubMedCrossRef Backhouse JL, Gidding HF, McIntyre PB, Gilbert GL (2006) Evaluation of two enzyme immunoassays for detection of immunoglobulin G antibodies to mumps virus. Clin Vaccine Immunol 13:764–767PubMedCrossRef
6.
go back to reference Garrido RM, Blanco QA, Garrote Adrados JA, Telleria Orriols JJ, Arranz SE (1997) Value of salivary antibodies for determining seropositivity to measles, rubella, and mumps in children and adults. An Esp Pediatr 47:499–504 Garrido RM, Blanco QA, Garrote Adrados JA, Telleria Orriols JJ, Arranz SE (1997) Value of salivary antibodies for determining seropositivity to measles, rubella, and mumps in children and adults. An Esp Pediatr 47:499–504
7.
go back to reference Gill J, Aston R, Vyse AJ, White JM, Greenwood A (2002) Susceptibility of young offenders to measles and rubella: an antibody prevalence study using oral fluid samples. Commun Dis Public Health 5:314–317PubMed Gill J, Aston R, Vyse AJ, White JM, Greenwood A (2002) Susceptibility of young offenders to measles and rubella: an antibody prevalence study using oral fluid samples. Commun Dis Public Health 5:314–317PubMed
8.
go back to reference Kremer JR, Muller CP (2005) Evaluation of commercial assay detecting specific immunoglobulin G in oral fluid for determining measles immunity in vaccinees. Clin Diagn Lab Immunol 12:668–670PubMedCrossRef Kremer JR, Muller CP (2005) Evaluation of commercial assay detecting specific immunoglobulin G in oral fluid for determining measles immunity in vaccinees. Clin Diagn Lab Immunol 12:668–670PubMedCrossRef
9.
go back to reference Nigatu W, Nokes DJ, Enquselassie F, Brown DW, Cohen BJ, Vyse AJ, Cutts FT (1999) Detection of measles specific IgG in oral fluid using an FITC/anti-FITC IgG capture enzyme linked immunosorbent assay (GACELISA). J Virol Methods 83:135–144PubMedCrossRef Nigatu W, Nokes DJ, Enquselassie F, Brown DW, Cohen BJ, Vyse AJ, Cutts FT (1999) Detection of measles specific IgG in oral fluid using an FITC/anti-FITC IgG capture enzyme linked immunosorbent assay (GACELISA). J Virol Methods 83:135–144PubMedCrossRef
10.
go back to reference Nokes DJ, Enquselassie F, Nigatu W, Vyse AJ, Cohen BJ, Brown DW, Cutts FT (2001) Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia. Bull World Health Organ 79:588–595PubMed Nokes DJ, Enquselassie F, Nigatu W, Vyse AJ, Cohen BJ, Brown DW, Cutts FT (2001) Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia. Bull World Health Organ 79:588–595PubMed
11.
go back to reference Perry KR, Brown DW, Parry JV, Panday S, Pipkin C, Richards A (1993) Detection of measles, mumps, and rubella antibodies in saliva using antibody capture radioimmunoassay. J Med Virol 40:235–240PubMedCrossRef Perry KR, Brown DW, Parry JV, Panday S, Pipkin C, Richards A (1993) Detection of measles, mumps, and rubella antibodies in saliva using antibody capture radioimmunoassay. J Med Virol 40:235–240PubMedCrossRef
12.
go back to reference Thieme T, Piacentini S, Davidson S, Steingart K (1994) Determination of measles, mumps, and rubella immunization status using oral fluid samples. JAMA 272:219–221PubMedCrossRef Thieme T, Piacentini S, Davidson S, Steingart K (1994) Determination of measles, mumps, and rubella immunization status using oral fluid samples. JAMA 272:219–221PubMedCrossRef
13.
go back to reference Brown DW, Ramsay ME, Richards AF, Miller E (1994) Salivary diagnosis of measles: a study of notified cases in the United Kingdom, 1991–3. BMJ 308:1015–1017PubMed Brown DW, Ramsay ME, Richards AF, Miller E (1994) Salivary diagnosis of measles: a study of notified cases in the United Kingdom, 1991–3. BMJ 308:1015–1017PubMed
14.
go back to reference Amela C, Pachon I, de Ory F (2003) Evaluation of the measles, mumps and rubella immunisation programme in Spain by using a sero-epidemiological survey. Eur J Epidemiol 18:71–79PubMedCrossRef Amela C, Pachon I, de Ory F (2003) Evaluation of the measles, mumps and rubella immunisation programme in Spain by using a sero-epidemiological survey. Eur J Epidemiol 18:71–79PubMedCrossRef
15.
16.
go back to reference Nardone A, Pebody RG, van den Hof S, Levy-Bruhl D, Plesner AM, Rota MC, Tischer A, Andrews N, Berbers G, Crovari P, Edmunds WJ, Gabutti G, Saliou P, Miller E (2003) Sero-epidemiology of mumps in western Europe. Epidemiol Infect 131:691–701PubMedCrossRef Nardone A, Pebody RG, van den Hof S, Levy-Bruhl D, Plesner AM, Rota MC, Tischer A, Andrews N, Berbers G, Crovari P, Edmunds WJ, Gabutti G, Saliou P, Miller E (2003) Sero-epidemiology of mumps in western Europe. Epidemiol Infect 131:691–701PubMedCrossRef
17.
go back to reference Dominguez A, Plans P, Costa J, Torner N, Cardenosa N, Batalla J, Plasencia A, Salleras L (2006) Seroprevalence of measles, rubella, and mumps antibodies in Catalonia, Spain: results of a cross-sectional study. Eur J Clin Microbiol Infect Dis 25:310–317PubMedCrossRef Dominguez A, Plans P, Costa J, Torner N, Cardenosa N, Batalla J, Plasencia A, Salleras L (2006) Seroprevalence of measles, rubella, and mumps antibodies in Catalonia, Spain: results of a cross-sectional study. Eur J Clin Microbiol Infect Dis 25:310–317PubMedCrossRef
18.
go back to reference Huerta M, Davidovitch N, Aboudy Y, Ankol OE, Balicer RD, Zarka S, Grotto I (2006) Declining population immunity to mumps among Israeli military recruits. Vaccine 24:6300–6303PubMedCrossRef Huerta M, Davidovitch N, Aboudy Y, Ankol OE, Balicer RD, Zarka S, Grotto I (2006) Declining population immunity to mumps among Israeli military recruits. Vaccine 24:6300–6303PubMedCrossRef
19.
go back to reference Janaszek-Seydlitz W, Bucholc B, Gorska P, Slusarczyk J (2005) Mumps in Poland since 1990 to 2003; epidemiology and antibody prevalence. Vaccine 23:2711–2716PubMedCrossRef Janaszek-Seydlitz W, Bucholc B, Gorska P, Slusarczyk J (2005) Mumps in Poland since 1990 to 2003; epidemiology and antibody prevalence. Vaccine 23:2711–2716PubMedCrossRef
20.
go back to reference Mossong J, Putz L, Schneider F (2004) Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study. Epidemiol Infect 132:11–18PubMedCrossRef Mossong J, Putz L, Schneider F (2004) Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study. Epidemiol Infect 132:11–18PubMedCrossRef
21.
go back to reference Vyse AJ, Gay NJ, Hesketh LM, Pebody R, Morgan-Capner P, Miller E (2006) Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century. Epidemiol Infect 134:1303–1312PubMedCrossRef Vyse AJ, Gay NJ, Hesketh LM, Pebody R, Morgan-Capner P, Miller E (2006) Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century. Epidemiol Infect 134:1303–1312PubMedCrossRef
22.
go back to reference Gay NJ, Vyse AJ, Enquselassie F, Nigatu W, Nokes DJ (2003) Improving sensitivity of oral fluid testing in IgG prevalence studies: application of mixture models to a rubella antibody survey. Epidemiol Infect 130:285–291PubMedCrossRef Gay NJ, Vyse AJ, Enquselassie F, Nigatu W, Nokes DJ (2003) Improving sensitivity of oral fluid testing in IgG prevalence studies: application of mixture models to a rubella antibody survey. Epidemiol Infect 130:285–291PubMedCrossRef
23.
go back to reference Madar R, Straka S, Baska T (2002) Detection of antibodies in saliva—an effective auxiliary method in surveillance of infectious diseases. Bratisl Lek Listy 103:38–41PubMed Madar R, Straka S, Baska T (2002) Detection of antibodies in saliva—an effective auxiliary method in surveillance of infectious diseases. Bratisl Lek Listy 103:38–41PubMed
24.
go back to reference Nigatu W, Nokes DJ, Afework A, Brown DW, Cutts FT, Jin L (2006) Serological and molecular epidemiology of measles virus outbreaks reported in Ethiopia during 2000–2004. J Med Virol 78:1648–1655PubMedCrossRef Nigatu W, Nokes DJ, Afework A, Brown DW, Cutts FT, Jin L (2006) Serological and molecular epidemiology of measles virus outbreaks reported in Ethiopia during 2000–2004. J Med Virol 78:1648–1655PubMedCrossRef
Metadata
Title
Detection of measles- and mumps-specific IgG antibodies in paired serum and oral fluid samples from Norwegian conscripts
Authors
K. Vainio
H. H. Samdal
G. Ånestad
E. Wedege
D. H. Skutlaberg
K. T. Bransdal
R. Mundal
I. S. Aaberge
Publication date
01-06-2008
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 6/2008
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-008-0460-3

Other articles of this Issue 6/2008

European Journal of Clinical Microbiology & Infectious Diseases 6/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine